BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17333296)

  • 1. Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer.
    Danjoux C; Gardner S; Fitch M
    Support Care Cancer; 2007 Oct; 15(10):1169-76. PubMed ID: 17333296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy.
    Monga U; Kerrigan AJ; Thornby J; Monga TN
    Radiat Oncol Investig; 1999; 7(3):178-85. PubMed ID: 10406060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.
    Truong PT; Berthelet E; Lee JC; Petersen R; Lim JT; Gaul CA; Pai H; Blood P; Ludgate CM
    Can J Urol; 2006 Jun; 13(3):3139-46. PubMed ID: 16813705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?
    Sanguineti G; Cavey ML; Endres EJ; Franzone P; Barra S; Parker BC; Marcenaro M; Colman M; Agostinelli S; Foppiano F; Vitale V
    Strahlenther Onkol; 2006 Sep; 182(9):543-9. PubMed ID: 16944377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal study of quality of life in patients with localized prostate cancer undergoing radiotherapy.
    Monga U; Kerrigan AJ; Thornby J; Monga TN; Zimmermann KP
    J Rehabil Res Dev; 2005; 42(3):391-9. PubMed ID: 16187251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy.
    Stone P; Richards M; A'Hern R; Hardy J
    J Pain Symptom Manage; 2001 Dec; 22(6):1007-15. PubMed ID: 11738163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of fatigue after treatment for prostate cancer.
    Maliski SL; Kwan L; Orecklin JR; Saigal CS; Litwin MS
    Urology; 2005 Jan; 65(1):101-8. PubMed ID: 15667873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue and other adverse effects in men treated by pelvic radiation and long-term androgen deprivation for locally advanced prostate cancer.
    Lilleby W; Stensvold A; Dahl AA
    Acta Oncol; 2016 Jul; 55(7):807-13. PubMed ID: 26959297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Occurring Symptoms Contribute to Persistent Fatigue in Prostate Cancer.
    Feng LR; Fuss T; Dickinson K; Ross A; Saligan LN
    Oncology; 2019; 96(4):183-191. PubMed ID: 30625479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding intensity-modulated radiotherapy to the pelvis does not worsen the adverse effect profiles compared to limited field radiotherapy in men with prostate cancer at 12-month follow-up.
    Lilleby W; Stensvold A; Dahl AA
    Acta Oncol; 2014 Oct; 53(10):1380-9. PubMed ID: 24844918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of a 12-week walking exercise program and its effect on fatigue in prostate cancer patients undergoing radical external beam radiotherapy.
    Truong PT; Gaul CA; McDonald RE; Petersen RB; Jones SO; Alexander AS; Lim JT; Ludgate C
    Am J Clin Oncol; 2011 Aug; 34(4):350-5. PubMed ID: 20686404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between fatigue, sleep quality and inflammatory cytokines during external beam radiation therapy for prostate cancer: A prospective study.
    Holliday EB; Dieckmann NF; McDonald TL; Hung AY; Thomas CR; Wood LJ
    Radiother Oncol; 2016 Jan; 118(1):105-11. PubMed ID: 26743832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy.
    Van Praet C; Ost P; Lumen N; De Meerleer G; Vandecasteele K; Villeirs G; Decaestecker K; Fonteyne V
    Radiother Oncol; 2013 Nov; 109(2):222-8. PubMed ID: 24016674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer.
    Greenberg DB; Gray JL; Mannix CM; Eisenthal S; Carey M
    J Pain Symptom Manage; 1993 May; 8(4):196-200. PubMed ID: 7963760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis.
    Song C; Kang HC; Kim JS; Eom KY; Kim IA; Chung JB; Hong SK; Byun SS; Lee SE
    Strahlenther Onkol; 2015 Oct; 191(10):801-9. PubMed ID: 26159555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.
    Forsythe K; Blacksburg S; Stone N; Stock RG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):630-5. PubMed ID: 22099032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer.
    Hickok JT; Roscoe JA; Morrow GR; Mustian K; Okunieff P; Bole CW
    Cancer; 2005 Oct; 104(8):1772-8. PubMed ID: 16116608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.
    Ishii K; Ogino R; Hosokawa Y; Fujioka C; Okada W; Nakahara R; Kawamorita R; Tada T; Hayashi Y; Nakajima T
    Br J Radiol; 2016 Jun; 89(1062):20150930. PubMed ID: 26959612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.